Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation

Yucel H., KAYA H. İ., Zorlu A., Yildirimli K., Sancakdar E., GÜNEŞ H., ...Daha Fazla

HERZ, cilt.40, ss.119-124, 2015 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s00059-014-4148-4
  • Dergi Adı: HERZ
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.119-124
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Hayır

Özet

Elevated cancer antigen 125 (CA-125) levels are associated with cardiopulmonary disorders such as acute and chronic heart failure (HF), coronary artery disease, chronic obstructive pulmonary disease, and atrial fibrillation (AF). The development of atrial fibrillation (AF) is related to morbidity and mortality in patients with HF: therefore, it is important to identify patients with increased risk for development of AF. We investigated whether plasma CA-125 levels in patients with hospitalized systolic HF could predict the development of AF.